Pharma and Biotech
CEO: | Trond Williksen |
CFO: | Septima Maguire |
Chairman: | Peter George |
Company Secretary: | Jennifer Haddouk |
Non-Executive Dir: | Torgeir Svae, Yngve Myhre, Marie Danielsson, Jonathan Esfandi, Kristian Eikre |
Address: | Highdown House, Yeoman Way, Worthing, West Sussex, United Kingdom, BN99 3HH |
Website: | http://www.bmkholdings.com |
Sector: | Pharma and Biotech(LSE) |
ISIN: | GB00BGHPT808 |
Currency | UK Pounds |
Share Price | 35.60p |
Change Today | -3.40p |
% Change | -8.72 % |
52 Week High | 48.00p |
52 Week Low | 34.00p |
Volume | 118,205 |
Shares Issued | 739.79m |
Market Cap | £263.37m |
Beta | 0.48 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
13:45 | 3 @ 35.64p |
12:40 | 44 @ 36.00p |
11:41 | 5,682 @ 36.00p |
11:41 | 6,318 @ 36.00p |
11:38 | 7,236 @ 35.61p |
Chair | Peter George |
CFO | Septima Maguire |
CEO | Trond Williksen |
You are here: research